Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
Hao Wang, Gurbakhash Kaur, Alexander Sankin, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

Macrophage-Based Approaches for Cancer Immunotherapy
Nicholas R. Anderson, Nicholas G. Minutolo, Saar Gill, et al.
Cancer Research (2020) Vol. 81, Iss. 5, pp. 1201-1208
Open Access | Times Cited: 503
The force awakens: metastatic dormant cancer cells
So‐Yeon Park, Jeong‐Seok Nam
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 4, pp. 569-581
Open Access | Times Cited: 161
Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
Rangarirai Makuku, Neda Khalili, Sepideh Razi, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-15
Open Access | Times Cited: 104
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Qiaofei Liu, Jiayi Li, Huaijin Zheng, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 71
TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells
Hao Wang, R. Alejandro Sica, Gurbakhash Kaur, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 27
Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
Yan-Ruide Li, Tyler Halladay, Lili Yang
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 24
Targeting immune checkpoints in hematological malignancies
Basit Salik, Mark J. Smyth, Kyohei Nakamura
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 106
Applying artificial intelligence for cancer immunotherapy
Zhijie Xu, Xiang Wang, Shuangshuang Zeng, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3393-3405
Open Access | Times Cited: 66
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
Yang Zhou, Miao Li, Kuangyi Zhou, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2266-2266
Open Access | Times Cited: 40
Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer
Jian Chen, Tianchuan Zhu, Guanmin Jiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 40
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
Ciliang Guo, Lingkai Kong, Lingjun Xiao, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Sonodynamic Therapy‐Driven Immunotherapy: Constructing AIE Organic Sonosensitizers Using an Advanced Receptor‐Regulated Strategy
Mengyan Tian, Yucong Li, Yaning Li, et al.
Small (2024)
Closed Access | Times Cited: 10
Checkpoint Inhibition Prior to Stem Cell Transplantation Increases the Risk of Inflammatory Adverse Events
Malek Shatila, Antonio Pizuorno Machado, Jay Shah, et al.
Targeted Oncology (2025)
Closed Access | Times Cited: 1
Determinants of response and resistance to CAR T cell therapy
Stefanie Lesch, Mohamed-Reda Benmebarek, Bruno L. Cadilha, et al.
Seminars in Cancer Biology (2019) Vol. 65, pp. 80-90
Closed Access | Times Cited: 74
Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
Eleni E Ladikou, Helena Sivaloganathan, Andrea Pepper, et al.
Current Oncology Reports (2020) Vol. 22, Iss. 3
Open Access | Times Cited: 56
T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies
Lu Tang, Yinqiang Zhang, Yu Hu, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-8
Open Access | Times Cited: 51
CARTmath—A Mathematical Model of CAR-T Immunotherapy in Preclinical Studies of Hematological Cancers
Luciana Rodrigues Carvalho Barros, Emanuelle Arantes Paixão, Andrea M. P. Valli, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 2941-2941
Open Access | Times Cited: 46
CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies
Yun Liang, Hui Liu, Zheming Lu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Cancer-associated inflammation: pathophysiology and clinical significance
Piotr Pęczek, Monika Gajda, Kacper Rutkowski, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 6, pp. 2657-2672
Open Access | Times Cited: 36
Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively
Zewei Tu, Qin Ouyang, Xiaoyan Long, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Mechanisms of CAR T cell exhaustion and current counteraction strategies
Xiaoying Zhu, Qing Li, Xiaojian Zhu
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 33
Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia
Jennifer Marvin‐Peek, Bipin N. Savani, Olalekan O. Oluwole, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 497-497
Open Access | Times Cited: 30
Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy
Kangdi Yang, Yuze Zhao, Guanqun Sun, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 20
Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy
Kai Kang, Yijun Wu, Zhuoran Yao, et al.
Cancer Letters (2023) Vol. 565, pp. 216239-216239
Open Access | Times Cited: 19
Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management
Khaled S. Allemailem, Mohammed A. Alsahli, Ahmad Almatroudi, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 5531-5559
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top